MITOMYCIN

NDC 65219-566 · Fresenius Kabi USA, LLC

Generic nameMITOMYCIN

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)MITOMYCIN

Strength20 mg/40mL

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

65219-566-20 — 1 VIAL in 1 CARTON (65219-566-20) / 40 mL in 1 VIAL

J9280 — Injection, mitomycin, 5 mg Medicare Part B payment limit (ASP + 6%): $34.11

FDA lists these products with the same active ingredient.

16729-108 — Mitomycin, 16729-115 — Mitomycin, 16729-116 — Mitomycin, 25021-250 — Mitomycin, 25021-251 — Mitomycin, 25021-252 — Mitomycin, 55150-450 — MITOMYCIN, 55150-451 — MITOMYCIN, 55150-452 — MITOMYCIN, 65219-564 — MITOMYCIN, 65219-568 — MITOMYCIN, 68001-389 — Mitomycin, 68001-390 — Mitomycin, 68001-391 — Mitomycin, 68001-615 — MITOMYCIN, 68001-616 — MITOMYCIN, 68001-617 — MITOMYCIN, 68083-483 — MITOMYCIN, 68083-484 — MITOMYCIN, 68083-502 — MITOMYCIN, +14 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.